• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    EU Moment of Truth For Abaloparatide & Advanced Therapy Tab-Cel

    PHARMAINTELLIGENCE

    Quince Presents Data Demonstrating Application of Bone-targeting Platform

    BUSINESSWIRE

    FDA Confirms Paragraph IV Patent Litigation for Tymlos (Abaloparatide)

    FDA

    Menarini Group’s Elacestrant Granted Priority Review by the U.S. FDA

    BUSINESSWIRE

    2 investment firms buy Radius, bone drug Tymlos for $890M

    FIERCEPHARMA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.